Home Cart Sign in  
Chemical Structure| 2306388-57-6 Chemical Structure| 2306388-57-6

Structure of PROTAC ERRα ligand 2
CAS No.: 2306388-57-6

Chemical Structure| 2306388-57-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ERRα degrader ligand 4a block the protein-protein interaction of ERRα with PGC-1α coactivator with IC50 value of 5.67nM in a TR-FRET assay.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PROTAC ERRα ligand 2

CAS No. :2306388-57-6
Formula : C20H13F6NO4
M.W : 445.31
SMILES Code : O=C(O)/C(C#N)=C/C1=CC=C(OCC2=CC=C(C(F)(F)F)C=C2C(F)(F)F)C(OC)=C1
MDL No. :MFCD32215326
InChI Key :JRWKJGIKIBTXMV-AWNIVKPZSA-N
Pubchem ID :139291005

Safety of PROTAC ERRα ligand 2

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

Description
PROTAC ERRα ligand 2 serves as an inverse agonist for estrogen-related receptor α (ERRα) with an IC50 of 5.67 nM. It demonstrates approximately an 11-fold increase in potency compared to XCT790, which has an IC50 of 61.3 nM[1].

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.25mL

0.45mL

0.22mL

11.23mL

2.25mL

1.12mL

22.46mL

4.49mL

2.25mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories